Private Advisor Group’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Sell
2,978
-35,504
-92% -$3.14M ﹤0.01% 2238
2025
Q4
$3.09M Sell
38,482
-7,413
-16% -$621K 0.01% 836
2025
Q3
$4.48M Sell
45,895
-2,740
-6% -$221K 0.02% 666
2025
Q2
$3.39M Sell
48,635
-4,940
-9% -$282K 0.02% 731
2025
Q1
$2.66M Buy
53,575
+47,510
+783% +$3M 0.02% 773
2024
Q4
$424K Buy
+6,065
New +$504K ﹤0.01% 1669
2020
Q3
Sell
-265
Closed -$7K 1569
2020
Q2
$7K Buy
+265
New +$6.46K ﹤0.01% 3058

Other funds holding ACLS

Private Advisor Group's ACLS Position: Q1 2026 in Review

Private Advisor Group reduced its Axcelis (ACLS) stake by 92% in Q1 2026, selling an estimated $3.14M and leaving 2,978 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #2238.

Private Advisor Group first reported a position in ACLS in Q2 2020 and has held it in 7 quarters since. The position peaked at $4.48M in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Private Advisor Group held 2,978 shares of Axcelis worth $277K as of Q1 2026.
  • Private Advisor Group sold 35,504 Axcelis shares in Q1 2026, an estimated $3.14M.
  • Axcelis made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2238 holding.
  • Private Advisor Group first reported a position in Axcelis in Q2 2020 and has held it in 7 quarters since.
  • Private Advisor Group's Axcelis position peaked at $4.48M in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.